References
- World Health Organization. Global tuberculosis report. 2014. Google Scholar
- Claude Mambo Muvunyi and Florence Masaisa. Diagnosis of Smear-Negative Pulmonary Tuberculosis in low-income countries: current Evidence in Sub-Saharan Africa with Special Focus on HIV Infection. 2012. Google Scholar
- Nakiyingi L, Bwanika JM, Kirenga B, Nakanjako D, Katabira
C et al. Clinical Predictors and Accuracy of Empiric Tuberculosis Treatment
among Sputum Smear-Negative HIV-Infected Adult TB Suspects in Uganda. PLoS
ONE. 2013; 8(9): e74023. PubMed | Google
Scholar
- Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis. 2011 Mar; 15(3): 287-95. PubMed | Google Scholar
- World Health Organization. Monitoring of Xpert MTB/RIF roll-out. Available at http://who.int/tb/laboratory/mtbrifrollout. Accessed Feb 2 2014. Google Scholar
- WHO. Policy Statement on Xpert MTB-RIF, Update. 2014. http://tbevidence.org/wp-content/uploads/2014/04/WHO-Xpert-Policy-Update.pdf. Accessed Mar-20-2015. Google Scholar
- Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014 Jan 21; 1: CD009593. PubMed | Google Scholar
- Walusimbi S, Bwanga F, De Costa A, Haile M, Joloba M, Hoffner S. Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis. 2013 Oct 30; 13: 507. PubMed | Google Scholar
- WHO. Xpert MTB/RIF implementation manual. 2014. http://tbevidence.org/wp-content/uploads/2014/04/Xpert-implementation-Manual-2014.pdf. Accessed Mar-10-2015. Google Scholar
- Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF-negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013; 103(2): 101-106. PubMed | Google Scholar
- Alamo ST, Kunutsor S, Walley J, Thoulass J, Evans M, Muchuro S, Matovu A, Katabira E. Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda. Trop Med Int Health. 2012; 17(7): 884-895. PubMed | Google Scholar
- Wekesa C, Kirenga BJ, Joloba ML, Bwanga F, Katamba A, Kamya MR. Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda. Int J Tuberc Lung Dis. 2014; 18(2): 216-219. PubMed | Google Scholar
- Stall N, Rubin T, Michael JS, Mathai D, Abraham OC, Mathews P, Thomas K, John M, Daley P. Does solid culture for tuberculosis influence clinical decision making in India? Int J Tuberc Lung Dis. 2011 May; 15(5): 641-6. PubMed | Google Scholar
- Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop Med Int Health. 2012; 17(9):1142-1151. PubMed | Google Scholar
- Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014 Feb 1; 383(9915): 424-35. PubMed | Google Scholar
- Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K et al. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care Xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS ONE. 2013; 8(6): e65421. PubMed | Google Scholar
- WHO: Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. In. Geneva; 2007. Google Scholar
- Published evidence and commentary on the Xpert MTB/RIF assay. Updated 12, March 2014. http://www.stoptb.org/wg/gli/assets/documents/map/XpertPublications.pdf. Accessed Mar-14-2015. Google Scholar
- Wilkinson D, Newman W, Reid A, Squire SB, Sturm AW, Gilks CF. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis. 2000 Jun; 4(6): 513-8. PubMed | Google Scholar
- Walusimbi S, Bwanga F, Costa AD, Haile M, Hoffner S, Joloba M. Evaluation of the Xpert MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients. Int J Mycobacteriol. 2013 Sep; 2(3): 148-55. PubMed | Google Scholar
- Stephen Lawn D, Andrew Kerkhoff D, Monica Vogt, Yonas Ghebrekristos, Andrew Whitelaw, Robin Wood. Characteristics and early outcomes of patients with xpert mtb/rif-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis. 2012; 54(8): 1071-1079. PubMed | Google Scholar
- WHO: Laboratory services in tuberculosis control culture. Part III. Geneva: Switzerland. In: Culture examination and identification. WHO/TB/98.258. edn; 1998. Google Scholar
- Brian Bell G, Francois Schellevis, Ellen Stobberingh HG, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014 Jan 9; 14: 13. PubMed | Google Scholar
- Sanjay Jain K, Bishai WR. Adherence to therapy, treatment success, and prevention of resistance. Infectious Dis Clin Pract. 2006; 14(4): S15-S18. PubMed | Google Scholar
- Tun-Chieh Chen, Po-Liang Lu, Chun-Yu Lin, Wei-Ru Lin, Chen Y-H. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2011; 15: e211-e216. PubMed | Google Scholar
- Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H et al. Antibiotic resistance-the need for global solutions. The Lancet Infectious diseases. 2013; 13(12): 1057-1098. PubMed | Google Scholar
- Okwera A, Bwanga F, Najjingo I, Mulumba Y, Mafigiri DK, Whalen CC, Joloba ML. Aetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional study. PloS one. 2013; 8(12): e82257. PubMed | Google Scholar
- Ginsburg AS, Tinkham L, Riley K, Kay NA, Klugman KP, Gill CJ. Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies. International journal of antimicrobial agents. 2013; 42(6): 482-491. PubMed | Google Scholar
- Huerga H, Varaine F, Okwaro E, Bastard M, Ardizzoni E, Sitienei J, Chakaya J, Bonnet M. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting. PloS one. 2012; 7(12): e51336. PubMed | Google Scholar
- Uganda AIDS Commission. Global AIDS response progress report. April 2012. Available at: Http://www.Unaids.Org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/. Accessed Nov-10-2014. Google Scholar